Implant survival of cemented arthroplasty following failed fixation of proximal femoral fractures in patients aged 30–60 years: a retrospective study with a median follow-up of 10 years

• Published in: BMC musculoskeletal disorders Vol. 23; no. 1; pp. 1 - 637
• Main Authors: Yu, Mingliang, Yu, Minji, Zhang, Yaodong, Cheng, Huihui, Zeng, Xianshang, Li, Si, Yu, Weiguang
• Format: Journal Article
• Language: English
• Published: London BioMed Central Ltd 04-07-2022; BioMed Central; BMC
• Subjects: Age; Alzheimer's disease; Arthroplasty; Artificial hip joints; Body mass index; Comorbidity; Failure; Femur; Fixation; Fracture; Fractures; Hip; Hip joint; Infections; Internal fixation in fractures; Joint surgery; Musculoskeletal diseases; Orthopedics; Patient outcomes; Patients; Prostheses; Revision; Skin & tissue grafts; Statistics; Survival; Titanium; Transplants & implants; Trends; China
• ISSN: 1471-2474; 1471-2474
• DOI: 10.1186/s12891-022-05587-0

Background Given the unremitting growth in the volume of failed fixations of proximal femoral fractures (PFFs) in recent years, it is predictable that total hip replacements (THRs) will be the preferred surgical procedure. The long-term survival of cemented THR (CTHR) revisions remains controversial in patients aged 30-60 years. The goal of this retrospective review was to evaluate the 10-year survival of CTHRs following prior failed primary fixations of PFFs in patients aged 30-60 years. Methods We retrospectively identified CTHR revisions implemented at four medical centres during 2008-2017 for a failed primary fixation of PFFs in consecutive patients aged 30-60 years. The primary endpoint was implant survival calculated using the Kaplan-Meier method with 95% confidence intervals (CIs); secondary endpoints included functional scores assessed by Harris hip scores (HHS) and main revision-related orthopaedic complications. Follow-up was executed at 1, 2, 3, and 8 years following revision and then at 1-year intervals until the revision, death, or study deadline, whichever occurred first. Results In total, 120 patients (120 hips) who met the eligibility criteria were eligible for follow-up. The median follow-up was 10.2 years (range, 8-12 years). Kaplan-Meier survivorship showed that implant survival with revision for any reason as the endpoint was 95% at 5 years (CI: 93-97%), 89% at 8 years (CI: 86-92%), and 86% at 10 years (CI: 83-89%). Patients treated with three hollow screws had better revision-free survival than patients treated with proximal femoral nail antirotation (PFNA), dynamic hip screw (DHS) or titanium plate plus screws (three p < 0.05). Functional scores were apt to decrease gradually, and at the final follow-up, the mean HHS was 76.9 (range, 67.4-86.4). The overall rate of main revision-related orthopaedic complications was 18.3% (22/120). Conclusion CTHR implemented following prior failed primary fixations of PFFs tends to afford an acceptable 10-year survival, along with advantageous HHS and a low rate of main revision-related orthopaedic complications, which may support an inclination to follow the utilisation of CTHRs, especially in revision settings for intracapsular fractures. Keywords: Survival, Fracture, Arthroplasty, Fixation, Revision